Repurposed drugs

**Dichloroacetate (DCA)** is a small molecule that’s been studied for its potential **anti-cancer effects**, especially due to its ability to target **cancer cell metabolism**. --- ### **Mechanism of Action** DCA…

Naltrexone is a non-selective opioid receptor antagonist, primarily used at standard doses (50–100 mg/day) to treat opioid and alcohol dependence. At low doses (0.5–6 mg/day, termed low-dose naltrexone or LDN),…

Niclosamide, an FDA-approved antihelminthic drug traditionally used to treat tapeworm infections, has shown promising preclinical activity against prostate cancer, particularly castration-resistant prostate cancer (CRPC). Its potential as an anticancer agent…

Ivermectin, an antiparasitic drug, has shown potential anticancer effects in preclinical studies for prostate cancer, but evidence in humans is limited and inconclusive. Here's a concise overview based on available…

Fenbendazole, a benzimidazole anthelmintic primarily used to treat parasitic infections in animals, has gained attention for its potential anticancer properties, including in prostate cancer. Below is a summary of the…

Methylene Blue (MB) is a synthetic dye with a long history of medical use, primarily for treating methemoglobinemia. Recent research has explored its potential as an anticancer agent, including for…

Dimethyl sulfoxide (DMSO) is a chemical solvent with anti-inflammatory, analgesic, and antioxidant properties, often studied for its potential in medical applications, including cancer treatment. Its use in prostate cancer has…